GR3005208T3 - - Google Patents
Info
- Publication number
- GR3005208T3 GR3005208T3 GR920401474T GR920401474T GR3005208T3 GR 3005208 T3 GR3005208 T3 GR 3005208T3 GR 920401474 T GR920401474 T GR 920401474T GR 920401474 T GR920401474 T GR 920401474T GR 3005208 T3 GR3005208 T3 GR 3005208T3
- Authority
- GR
- Greece
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85854286A | 1986-04-29 | 1986-04-29 | |
| US07/011,792 US4965065A (en) | 1986-04-29 | 1987-02-06 | Gastroprotective process and compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3005208T3 true GR3005208T3 (en:Method) | 1993-05-24 |
Family
ID=26682793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR920401474T GR3005208T3 (en:Method) | 1986-04-29 | 1992-07-16 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4965065A (en:Method) |
| EP (1) | EP0248150B1 (en:Method) |
| DE (1) | DE3780361T2 (en:Method) |
| ES (1) | ES2042511T3 (en:Method) |
| GR (1) | GR3005208T3 (en:Method) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01197444A (ja) * | 1986-03-04 | 1989-08-09 | Bristol Myers Co | 非ステロイド系抗炎症組成物によって生じる消化管損傷に対するβ−アドレナリン作用薬とある種のヒスタミンＨ↓１−および／またはＨ↓２−受容体遮断薬との組合せの効果 |
| US5043358A (en) * | 1986-03-04 | 1991-08-27 | Bristol-Myers Squibb Company | Gastroprotective process |
| EP0321613A1 (en) * | 1987-12-18 | 1989-06-28 | Bristol-Myers Company | The effect of a combination of a beta-adrenergic agonist and certain histamine H1- and/or H2-receptor blockers on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions |
| EP0320550A1 (en) * | 1987-12-18 | 1989-06-21 | Bristol-Myers Company | Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent |
| US5071842A (en) * | 1988-10-14 | 1991-12-10 | Bristol-Myers Squibb Company | Aspirin-containing composition including diphenhydramine and an alkalizing agent to reduce gastrointestinal injury potential |
| EP0509036B1 (en) * | 1990-01-05 | 1996-03-27 | Sepracor, Inc. | Optically pure r(-) albuterol for treating asthma |
| EP0556880A3 (en) * | 1992-01-22 | 1993-10-27 | Glaxo Group Limited | Medical use for atypical beta-adrenoceptor agonists |
| IS4198A (is) * | 1993-08-13 | 1995-02-14 | Somatogen, Inc | Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða |
| SE0000773D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
| SE0000774D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
| US6926907B2 (en) * | 2001-06-01 | 2005-08-09 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| SE0102993D0 (sv) | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
| EP1613266A4 (en) * | 2003-04-15 | 2009-05-06 | Theraquest Biosciences Llc | METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF |
| DE10356112A1 (de) * | 2003-11-27 | 2005-06-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem in den Prostglandinstoffwechsel eingreifendem Wirkstoff |
| US7488107B2 (en) * | 2005-08-18 | 2009-02-10 | General Electric Company | Method and apparatus to detect and correct alignment errors in x-ray systems used to generate 3D volumetric images |
| EP2207537B1 (en) * | 2007-10-02 | 2017-06-14 | Fremont Group Ltd | Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alpha-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength |
| US9220698B2 (en) | 2008-09-09 | 2015-12-29 | Pozen Inc. | Method for delivering a pharmaceutical composition to patient in need thereof |
| CN102481293A (zh) | 2009-06-25 | 2012-05-30 | 阿斯利康(瑞典)有限公司 | 治疗具有发展nsaid-相关的溃疡的风险的患者的方法 |
| CA2860231A1 (en) | 2011-12-28 | 2013-07-04 | Pozen Inc. | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4025624A (en) * | 1975-11-18 | 1977-05-24 | A. H. Robins Company, Incorporated | Phenylalkylamines and phenylalkylureas in combinations to suppress gastric bleeding in aspirin therapy |
| US4564614A (en) * | 1984-10-11 | 1986-01-14 | Pfizer Inc. | Antiinflammatory methods |
-
1987
- 1987-02-06 US US07/011,792 patent/US4965065A/en not_active Expired - Lifetime
- 1987-03-06 EP EP87103264A patent/EP0248150B1/en not_active Expired - Lifetime
- 1987-03-06 ES ES87103264T patent/ES2042511T3/es not_active Expired - Lifetime
- 1987-03-06 DE DE8787103264T patent/DE3780361T2/de not_active Expired - Lifetime
-
1992
- 1992-07-16 GR GR920401474T patent/GR3005208T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE3780361D1 (de) | 1992-08-20 |
| ES2042511T3 (es) | 1993-12-16 |
| DE3780361T2 (de) | 1992-12-17 |
| EP0248150A1 (en) | 1987-12-09 |
| EP0248150B1 (en) | 1992-07-15 |
| US4965065A (en) | 1990-10-23 |